Boston Scientific Corp
Change company Symbol lookup
Select an option...
BSX Boston Scientific Corp
GOLD Barrick Gold Corp
AMZN Amazon.com Inc
NFLX Netflix Inc
CDTX Cidara Therapeutics Inc
XBTAX BlackRock Long Term Municipal Advantage Trust
PBYA Probility Media Corp
RA Brookfield Real Assets Income Fund Inc.
PAA Plains All American Pipeline LP
$ESDOWD DOW JONES SPAIN STK US$ NDX
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Closing Price
$35.38
Day's Change
0.10 (0.28%)
Bid
--
Ask
--
B/A Size
--
Day's High
36.05
Day's Low
35.29
Volume
(Light)
Volume:
4,738,385

10-day average volume:
13,690,721
4,738,385

Boston Scientific to Participate in Jefferies 2020 Healthcare Conference

9:30 am ET May 26, 2020 (PR Newswire) Print

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies 2020 Virtual Healthcare Conference on June 2.

https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.jpg

Joe Fitzgerald, executive vice president and president, Rhythm Management; Kenneth Stein, M.D., senior vice president and chief medical officer, Global Health Policy and Rhythm Management; Mark Bickel, vice president, controller, Rhythm Management; and Susie Lisa, vice president, Investor Relations will participate in a 25-minute question-and-answer session with the host analyst beginning at approximately 8 a.m. EDT.

A live webcast and replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors. The replay will be available beginning approximately one hour following the completion of the event.

About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS
Media:                        Investors:
Katie Schur                   Susie Lisa, CFA
508-683-5574 (office)         508-683-5565 (office)
Media Relations               Investor Relations
Boston Scientific Corporation Boston Scientific Corporation
Katie.Schur@bsci.com          BSXInvestorRelations@bsci.com

https://c212.net/c/img/favicon.png?sn=NE17146&sd=2020-05-26

View original content to download multimedia:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-jefferies-2020-healthcare-conference-301065155.html

SOURCE Boston Scientific Corporation

https://rt.prnewswire.com/rt.gif?NewsItemId=NE17146&Transmission_Id=202005260930PR_NEWS_USPR_____NE17146&DateId=20200526

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.